Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.

AG1478 HCl

  Cat. No.:  DC34347   Featured
Chemical Structure
170449-18-0
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
AG1478 HCl is an inhibitor of epidermal growth factor receptor protein.
Cas No.: 170449-18-0
Chemical Name: AG 1478 Hydrochloride
Synonyms: 6,7-Dimethoxy-4-[N-(3-chlorophenyl)amino]quinazoline hydrochloride;4-Quinazolinamine,N-(3-chlorophenyl)-6,7-dimethoxy-, hydrochloride (1:1);AG 1478 hydrochloride;AG-1478 (TYRPHOSTIN AG-1478);N-(3-chlorophenyl)-6,7-dimethoxy-4-Quinazolinamine hydrochloride;N-(3-Chlorophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride;-6,7-dimethoxyquinazolin-4-amine hydrochloride;N-(3-chlorophenyl)-6,7-dimethoxy- hydrochloride;AG 1478;QP952C4RUW;4-(3-CHLOROANILINO)-6,7-DIMETHOXYQUINAZOLINE HYDROCHLORIDE;N-(3-Chlorophenyl)-6,7-dimethoxy-4-quinazolinamine monohydrochloride;4-(3-Chloroanilino)-6,7-dimethoxyquinazoline HCl;4-Quinazolinamine, N-(3-chlorophenyl)-6,7-dimethoxy-, monohydrochloride;Tyrphostin hydrochloride;170;AG-1478 hydrochloride;BMK1-C6;6,7-DIMETHOXY-4-(N-(3-CHLOROPHENYL)AMINO)QUINAZOLINE HYDROCHLORIDE;N-(3-CHLOROPHENYL)-6,7-DIMETHOXY-4-QUINAZOLINAMINE HYDROCHLORIDE;FT-0651476;N-(3-Chlorophenyl)-6,7-dimethoxy-4-quinazolinanine hydrochloride;UNII-QP952C4RUW;NCGC00180910-01;SMR000466282;4-Quinazolinamine, N-(3-chlorophenyl)-6,7-dimethoxy-, hydrochloride (1:1);AG1478 HCl;CS-0019985;AG1478 hydrochloride;HY-13524A;MLS000758209;N-(3-Chlorophenyl)-6,7-dimethoxyquinazolin-4-amine HCl;DTXSID4057891;TYRPHOSTIN AG 1478 HYDROCHLORIDE;AG-1478 HCl;N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride;170449-18-0;AG-1478 (hydrochloride);BCP9000245;BCP01312;SCHEMBL5477838;170449-18-0 pound not153436-53-4;AG 1478 HYDROCHLORIDE;BCPP000425;AG 1478 HCl;AG-1478.hcl;AM808089;RTKI cpd;N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine;hydrochloride;DS-13538;SR-01000076156-3;CHEMBL540068;SR-01000076156;AKOS005146488;Tyrphostin AG-1478 hydrochloride;AG 1478 hydrochloride;NSC 693255 hydrochloride;AG1478 hydrochloride;Tyrphostin AG-1478 hydrochloride;NSC 693255 hydrochloride;N-(3-chlorophenyl)-6,7-diMethoxyquinazolin-4-aMine hydrochloride;N-(3-Chlorophenyl)-6,7-dimethoxy-4-quinazolinamine hydrochloride
SMILES: ClC1=C([H])C([H])=C([H])C(=C1[H])N([H])C1C2=C([H])C(=C(C([H])=C2N=C([H])N=1)OC([H])([H])[H])OC([H])([H])[H].Cl[H]
Formula: C16H15Cl2N3O2
M.Wt: 352.2152
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
Cat. No. Product name Field of application
DC31074 Isopropyl myristate Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868 AZ14133346 AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865 TI17 ​​TI17​​ represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816 Nisoxetine Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641 GENZ-644282 TFA salt Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325 PSMA-617 TFA PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202 Fosaprepitant free acid Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748 O4I4 O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684 ZH8667 ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646 EB-PSMA-617 EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.
X